Viatris Inc. (VTRS)
$17.44+1.10%Close
BUYBULL · day 20
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $20.3B
- Beta
- 0.86
- Div yield
- 2.75%
- P/E (TTM)
- -48.44
- Short % float
- 3.66%
- Days to cover
- 4.2
- SI change
- +3.1%
- 1W
- -0.29%
- 1M
- +4.74%
- vs SPY 1W
- +0.69%
- vs SPY 1M
- +2.88%
Industry peers
FMP comparable companies · ranked by market cap
- TEVABUYTeva Pharmaceutical Industries Limited$47.9BBULLQ 13$41.10-1.28%
- HLNBUYHaleon plc$41.0BRECOVERYQ 19$9.32+2.54%
- RDYBUYDr. Reddy's Laboratories Limited$10.4BRECOVERYQ 16$12.48-0.16%
- ALKSSELLAlkermes plc$6.8BCRISISQ 6$40.61-1.64%
- AMRXBUYAmneal Pharmaceuticals, Inc.$6.4BBEARQ 15$19.91-3.42%
- OGNBUYOrganon & Co.$3.6BBULLQ -2$13.81-0.22%
- BHCSELLBausch Health Companies Inc.$2.3BRECOVERYQ 2$6.04+0.00%
- ANIPSELLANI Pharmaceuticals, Inc.$1.7BRECOVERYQ 9$73.89-0.96%
- AMPHBUYAmphastar Pharmaceuticals, Inc.$1.2BRECOVERYQ 9$26.62+0.12%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on VTRS?
- LOPJLB’s latest quantitative signal on Viatris Inc. (VTRS) is BUY in a BULL regime. Signals are updated daily.
- What market regime is VTRS in?
- Viatris Inc. (VTRS) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Viatris Inc. (VTRS) do?
- Viatris Inc. operates as a global pharmaceutical and healthcare enterprise. Its business is structured across four primary geographic divisions: Developed Markets, Greater China, JANZ (Japan, Australia, New Zealand), and Emerging Markets. The company offers a comprehensive range of pharmaceutical products, encompassing branded prescription medications, generic and complex generic drugs, biosimi…